Boston Millennia Partners
Venture capitalBoston · Seed–Late Stage · 8 people tracked
Also known as Boston Millennia Partners Limited Partnership · GLEN VENTURES MANAGMENT, INC
Find your way into Boston Millennia Partners
646 people in our graph share verified history with the Boston Millennia Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Boston Millennia Partners is a private equity firm that invests in healthcare and life sciences companies.
Source: firm website, verified Jul 28, 2026.
Team · 8 people
from curated & public directoriesFounder mafia
2 people who came through Boston Millennia Partners went on to found or lead other companies.
What they invest in
from 8 of 9 portfolio companiesHealthtech ×6AI & Machine Learning ×5Medical Devices ×4Digital Health ×3Enterprise Software ×3SaaS ×3Biotech ×2HR Tech ×1
HQs:United States×7
Investments · 9 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 12021 · 12018 · 15 dated
Collegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions.
BiotechCanton, US
Michael Heffernan(Executive Officer, Director)inPaul Brannelly(Executive Officer)inVikram Karnani(President and Chief Executive Officer, and Director)in
BoardEran Nadav(Director)John Freund(Director)Patrick Heron(Director)in
Co-investorsAPERTURE Venture PartnersEcoR1 CapitalFrazier Life SciencesLongitude CapitalRA Capital
HRSoft is a provider of enterprise compensation management software that enables organizations to design, manage, and automate complex pay programs including merit, bonus, equity, and incentive plans.
AI & Machine LearningEnterprise SoftwareHealthtechHR TechMedical DevicesSaaSPhiladelphia, US
Joe Poxson(Chief Executive Officer)
Co-investorsExcelerate Health VenturesRittenhouse VenturesRobin Hood VenturesStrattech Partners, LLCTech Council Ventures
Hyperion Biosystems builds diagnostic devices that use computer vision and physics-based algorithms to improve the sensitivity and specificity of point-of-care and at-home tests.
AI & Machine LearningHealthtechMedical Devices
Co-investorsNewlin Investment Company LLCSafar PartnersBreakout LabsCranberry CapitalPropel Venture Partners
Korio provides RTSM (Randomization and Trial Supply Management) software for clinical trials, with a focus on experienced project management and continuity throughout the study lifecycle.
BiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSDoylestown, US
Ryan Keane(Executive Officer, Director)inChuck Harris(Executive Officer, Director)in
BoardAustin Poole(Director)Hugh R. Roome(Director)B. Bobby Bahram(Director)in
Co-investorsBIP VenturesExcelerate Health Ventures
Reveleer provides a unified platform combining AI-powered retrieval, clinical intelligence, risk adjustment, and quality improvement tools for healthcare providers and health plans operating under value-based care models.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtech
Co-investorsOak HC/FTUpfront VenturesHercules Capital, Inc.
S2N Health provides commercial intelligence, analytics, and go-to-market strategy services for medtech, diagnostics, digital health, and drug delivery companies, from startups to global enterprises.
AI & Machine LearningHealthtechMedical DevicesSales TechBoston, US
Amy Siegel(CEO & Co-Founder)inTim Kofol(CTO & Co-Founder)inLeah Shea(Chief Product Officer)in
BoardRoome Hugh(Director)Andrew Schwab(Director)inMartha Shadan(Director)in
Co-investorsExcelerate Health VenturesRittenhouse VenturesRobin Hood Ventures
Xevant offers an automated data analytics and reporting platform for pharmacy benefit organizations, using AI to standardize diverse data formats, analyze pharmacy claims, and generate reports and repricing outputs.
AI & Machine LearningDigital HealthSaaSLehi, US
Brandon Newman(CEO)inPETE TANTILLO(Executive Officer)JEFF LININGER(Executive Officer)DANIEL TELFORD(Executive Officer)DON DEGOYLER(Director)NICK CONWAY(Director)
Co-investorsHCAP PartnersTech Council VenturesMartinson VenturesTCV
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsCollegium PharmaceuticalNASDAQ: COLL
Portfolio news
latest coverage across their companiesXevant · globenewswire.com · Aug 13, 2026

Collegium Pharmaceutical · kalkinemedia.com · Aug 13, 2026
Cota · chiefhealthcareexecutive.com · May 18, 2026
Rittenhouse Ventures · pulse2.com · Nov 5, 2025
Reveleer · founderpath.com · Oct 8, 2025
S2N Health · s2nhealth.com · Aug 11, 2025
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Collegium Pharmaceutical | 4.6% | $20.00 | Jan 2016 | $21.6M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Boston Millennia Partners made?
- Boston Millennia Partners has 9 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Boston Millennia Partners invest at?
- Boston Millennia Partners invests at the Seed, Growth, Late Stage stages.
- What is Boston Millennia Partners's typical check size?
- Boston Millennia Partners typically writes checks of $3M – $5M.
- What sectors does Boston Millennia Partners focus on?
- Boston Millennia Partners focuses on Biotech, Enterprise Software, Healthtech, Medical Devices, SaaS.
- Where is Boston Millennia Partners located?
- Boston Millennia Partners is headquartered in Boston, US.
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
Mitsui Global Investment is an investment firm that provides capital and hands-on support to entrepreneurs, helping innovative teams scale their businesses onto the global stage.
SpringRock Ventures is a Seattle-based venture firm investing in the convergence of healthcare and information technology, backing companies across digital health, medical devices, oral health, healthcare SaaS and related innovation.







































